Product Details
| Packaging Type | Box |
| Composition | Tacillizumab |
| Packaging Size | Pack Of 100 |
| Form | Tablet |
| Manufacturer | CIPLA |
| Strength / Dose | 40 mg / 0.8 ml |
Interleukin-6 (IL-6), a protein implicated in inflammation, is inhibited by tacilizumab. It lessens joint inflammation and slows the spread of the disease by inhibiting IL-6. Tacilizumab tablets are normally prescribed by a healthcare provider and may cause adverse effects, so its critical to adhere to the suggested dosage and seek advice from a physician.
Interested in this product?
Ask for more details & Latest Price from seller
One of the biggest companies in the nutraceutical industry, Zeroharm Sciences Private Limited, uses the most recent nanotechnology encapsulating techniques that are patent-pending and involve an aqueous, chemical-free extraction method. We began in the years 2020–21 and are well known throughout the industry for manufacturing, wholesaling, and exporting our items. As an established manufacturer and exporter of a variety of secure and trustworthy formulations, including tablets, capsules, active pharmaceutical ingredients, and curcumin granules, we are known around the world. We also offer services for third-party manufacturers.
